Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs ENPH✓SelectedUSD · ENPHMRNA vs ENPH performance historyLatest closeAs of+1.29%11/19
Stock and ETF performance explorer

MRNA vs ENPH

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-29.5%
ENPH return
-91.8%
Excess return
+62.3%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioENPHExcessAlpha
1D+1.3%-3.0%+4.3%+2.2%
7D-13.8%-17.9%+4.1%-8.7%
30D-17.7%-31.8%+14.1%-8.3%
3M+14.3%-44.2%+58.5%+34.4%
6M+336.0%-53.0%+389.0%+424.7%
YTD+575.9%-31.4%+607.3%+594.7%
1Y+724.4%-18.3%+742.6%+705.5%
3Y+160.8%-76.3%+237.1%+233.5%
All-29.5%-91.8%+62.3%+9.0%

Cumulative growth

Daily Returns

Daily percentage return beside ENPH.

Daily Out/Under-Performance

Portfolio return minus ENPH return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ENPH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded ENPH wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling